Bleomycin and Paraquat Mediated Pulmonary Fibrosis Is IL-17 Independent

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFABRO, A. T.
dc.contributor.authorPARRA, E. R.
dc.contributor.authorRAGEL, M. P.
dc.contributor.authorTEODORO, W. R.
dc.contributor.authorPOPPER, H. H.
dc.contributor.authorCAPELOZZI, V. L.
dc.date.accessioned2013-10-11T21:25:47Z
dc.date.available2013-10-11T21:25:47Z
dc.date.issued2012
dc.description.abstractBackground: Pulmonary fibrosis is a destructive process that in many cases are of unknown cause such as idiopathic pulmonary fibrosis. Better characterization of the immunological mechanisms of pulmonary fibrosis is needed to identify new therapeutic modalities for these diseases. The aim of the current study was to characterize the mechanisms of pulmonary fibrosis in the late phase and to determine whether IL-17A plays an important regulatory role. Design: The pulmonary fibrosis was induced in distinct animal models, including Bleomycin (B-BLM) and Paraquat (B-PQ) in Balb/c mice. Additionally, IL17-RA Knockout (IL17KO) and wild C57 mice (C-BLM) were included. We used the picrosirius-polarization method and weigert’s resorcin-fuchsin stain to morphometric study the peribronchiolar collagen and elastic fibers, respectively. By immunohistochemistry, we evaluate TGF-β, IL-21, IL-6, CD83, IL-17, IL-23, IL-13, STAT3, PDGF, FGF, TNF-α and limphocytic markers expression, using stereology method. The sacrifice of mice was performed 21 day after induction. Results: We report here that late PQ and BLM-mediated peribronchiolar fibrosis is IL-17 independent, as IL17-RA -/- mice developed similar peribronchiolar fibrosis after induction when compared to B-BLM, B-PQ and C-BLM (Fig left). We found that only B-BLM and B-PQ presented increase of elastic fibers and they show a positive correlation with the deposition of collagen fibers. In IL-17KO group TGF and collagen correlated. The B-BLM showed marked increase in dendritic cells (CD83) and T lymphocytes (CD3), but the IL-17 axis is suppressed by low expression of IL-23, IL-13 and IL-17 (tendency). In contrast, the mice without IL-17A receptor (IL17KO) showed overexpression of IL-17 axis by high expression of IL-17, IL-6, IL-21, STAT3 and CD8+ T cell. The B-PQ group has only increased FGF-β. Conclusions: Bleomycin and paraquat-mediated peribronchiolar fibrosis is IL-17 independent in the late phase. However, distinct mechanisms of peribronchiolar fibrosis may be involved, such as IL-17 response in C57 mice and presentation and processing of antigens in Balb/c mice. More studies are necessary to validate the regulatory role of IL-17 on pulmonary fibrosis process.
dc.description.conferencedateMAR 17-23, 2012
dc.description.conferencelocalVancouver, CANADA
dc.description.conferencename101st Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology
dc.description.indexMEDLINE
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipNational Counsel of Technological and Scientific Development (CNPq)
dc.identifier.citationMODERN PATHOLOGY, v.25, suppl.2, p.476A-476A, 2012
dc.identifier.issn0893-3952
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/3033
dc.language.isoeng
dc.publisherNATURE PUBLISHING GROUP
dc.relation.ispartofModern Pathology
dc.rightsrestrictedAccess
dc.rights.holderCopyright NATURE PUBLISHING GROUP
dc.subject.wosPathology
dc.titleBleomycin and Paraquat Mediated Pulmonary Fibrosis Is IL-17 Independent
dc.typeconferenceObject
dc.type.categorymeeting abstract
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.contributor.author-fmusphcEDWIN ROGER PARRA CUENTAS
hcfmusp.contributor.author-fmusphcMARISTELA PERES RANGEL
hcfmusp.contributor.author-fmusphcWALCY PAGANELLI ROSOLIA TEODORO
hcfmusp.contributor.author-fmusphcVERA LUIZA CAPELOZZI
hcfmusp.description.beginpage476A
hcfmusp.description.endpage476A
hcfmusp.description.issuesuppl 2
hcfmusp.description.volume25
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000299986902493
hcfmusp.publisher.cityNEW YORK
hcfmusp.publisher.countryUSA
hcfmusp.remissive.sponsorshipCNPq
hcfmusp.remissive.sponsorshipFAPESP
relation.isAuthorOfPublication6afb1872-f620-4b36-a50a-9001c6b5e301
relation.isAuthorOfPublication159b95b4-d083-4217-beb1-8dc5be13969b
relation.isAuthorOfPublication7d59bf88-68fc-4e9c-8666-7a872b110aa8
relation.isAuthorOfPublicationeabdbb85-f2d4-497a-a33c-81c972fe1a4b
relation.isAuthorOfPublication.latestForDiscovery6afb1872-f620-4b36-a50a-9001c6b5e301
Arquivos
Coleções
Comunicações em Eventos - FM/MPT
Comunicações em Eventos - FM/MCM
Comunicações em Eventos - HC/ICHC
Comunicações em Eventos - LIM/17